C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/1998
12/30/1998	EP0886637A1 Inhibitors of microsomal triglyceride transfer protein and method
12/30/1998	CA2294050A1 New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
12/29/1998	US5854249 Opioid diarylmethylpiperazines and piperidines
12/29/1998	US5854232 Acyclic anc cyclic amides as neurotransmitter release enhancers
12/29/1998	US5854008 Europium and terbium chelators for the time-resolved fluorometric assays
12/23/1998	WO1998057954A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998	WO1998057643A1 Use of draflazine-analogues for treating pain
12/23/1998	EP0885611A2 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
12/23/1998	EP0885212A1 Quinoxalinediones
12/23/1998	EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
12/23/1998	EP0885199A1 Kappa agonist compounds and pharmaceutical formulations thereof
12/23/1998	EP0813518B1 Process for preparing alpha,beta-diaminoacrylnitriles
12/23/1998	CN1202891A New quinoxalindione derivatives, their preparation and use in medicaments
12/23/1998	CA2294011A1 Use of draflazine-analogues for treating pain
12/23/1998	CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/22/1998	US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives
12/22/1998	US5852018 Pharmaceutical piperazine compounds
12/22/1998	US5852017 2,3(1H,4H)-quinoxalinediones
12/22/1998	US5852016 Quinoxaline derivatives useful in therapy
12/22/1998	US5852008 Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
12/22/1998	US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998	CA1340284C Herbicidal substituted cyclic diones
12/17/1998	WO1998056771A2 Piperazine derivatives and their use as anti-inflammatory agents
12/16/1998	EP0883403A1 Method for treating sexual dysfunctions
12/16/1998	CN1202159A Pyrazin-2-one derivatives, their use, and intermediates for their production
12/15/1998	US5849911 Antivirally active heterocyclic azahexane derivatives
12/15/1998	US5849775 Substituted benzoylguanidines process for their preparation, their use as a medicament or diagnostic, and pharmaceutical containing them
12/15/1998	US5849768 α-unsaturated amines, their production and use
12/15/1998	US5849742 Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis
12/15/1998	US5849732 Phenol compound having antioxidative activity and the process for preparing the same
12/10/1998	WO1998054966A1 A method of treating cancer
12/10/1998	WO1998040374A3 Olefin polymerization catalysts containing group 8-10 transition metals, bidentate ligands, processes employing such catalysts and polymers obtained therefrom
12/10/1998	CA2292471A1 A method of treating cancer
12/09/1998	EP0882024A1 Retroviral protease inhibiting compounds
12/09/1998	EP0882022A1 Aspartyl protease inhibitors
12/08/1998	US5846987 Retroviral protease inhibiting compounds
12/03/1998	WO1998054158A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/03/1998	WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998	WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998	WO1998053711A1 Dehydration plant
12/03/1998	CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998	CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998	CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/02/1998	EP0880893A1 Method for controlling algae
12/01/1998	US5843968 Symmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
12/01/1998	US5843967 6-membered nitrogen-containing heteroaryl-oxazolidinones
12/01/1998	US5843942 Aromatic amino ethers as pain relieving agents
11/1998
11/25/1998	EP0879818A1 Benz[g]quinoxalin-5,10-dione (=naphthoquinone) derivatives, their preparation and their use in electrophotographic material
11/25/1998	EP0879058A1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments
11/25/1998	CN1200120A Piperazino derivatives as neurokinin antagonists
11/24/1998	US5840954 Enhancing the storage stability of organic phosphites and phosphonites
11/24/1998	US5840896 Method of preventing or limiting reperfusion damage
11/24/1998	US5840724 Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or
11/24/1998	US5840723 Quinoxaline derivatives for treating tinnitus
11/19/1998	WO1998051298A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
11/18/1998	EP0877740A1 Thiol derivatives with metallopeptidase inhibitory activity
11/18/1998	EP0877612A1 Use of piperazine derivatives for the treatment of cognitive disorders
11/18/1998	EP0706514B1 Compounds and methods for inhibition of hiv and related viruses
11/18/1998	CN1199394A Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing same
11/17/1998	US5837873 Intermediates of retroviral protease inhibiting compounds
11/17/1998	US5837737 Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising same
11/17/1998	US5837707 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/17/1998	US5837016 Fuel additive
11/12/1998	WO1998050031A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050030A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050029A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998035951A3 New aminopiperazine derivatives
11/12/1998	CA2288330A1 Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
11/12/1998	CA2287300A1 Ligated platinum group metal catalyst complex and improved process for catalytically converting alkanes to esters and derivatives thereof
11/11/1998	EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998	EP0876357A1 New quinoxalindione derivatives, their preparation and use in medicaments
11/11/1998	EP0876353A1 Retroviral protease inhibiting compounds
11/11/1998	EP0876345A1 Heterocyclic compounds as h+-atpases
11/11/1998	EP0778832B1 Process for producing quaternary glycine nitriles
11/11/1998	EP0691970B1 Imidazoloquinoxalinone derivatives as eaa antagonists
11/11/1998	CN1198816A Polyoxyhydrocarbyl related products and methods for fluorescence assays
11/10/1998	US5834506 Treatment of hiv, aids; antiviral activity improved by judicious placement of polar substituents
11/10/1998	US5834401 Nitrogen-containing cyclic compounds and herbicides containing the same as active ingredient
11/09/1998	CA2237052A1 Substituted diaminocarboxylic acids
11/05/1998	WO1998013349A3 Heteroaryloxyethylamines as 5-ht1a ligands
11/04/1998	EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/04/1998	EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
11/04/1998	EP0874828A1 Composition for treating pain
11/04/1998	EP0655992B1 Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent
11/03/1998	US5830896 Psychological disorders; antiepilepic agents; alzheimer'sand parkinson?s disease
10/1998
10/29/1998	WO1998047933A1 Group 8-10 transition metal olefin polymerization catalysts
10/29/1998	WO1998047878A1 A process for the preparation of highly pure 6,7-dichloro-5- nitro-2,3-dihydroquinoxaline-2,3-dione
10/29/1998	WO1998047858A1 Chelate derivatives as protectors against tissue injury
10/29/1998	WO1998047362A1 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses
10/29/1998	CA2288075A1 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses
10/29/1998	CA2285648A1 Group 8-10 transition metal olefin polymerization catalysts
10/28/1998	EP0873356A1 Novel dipeptide amidines as thrombin inhibitors
10/28/1998	EP0873321A1 Novel amido quinoxaline diones, their production and use
10/28/1998	EP0873320A1 Piperazine derivatives as tachykinin antagonists
10/28/1998	EP0627406B1 2-amino-1,3-propanediol compound and immunosuppressant
10/28/1998	EP0476016B1 CNS active 8-heterocyclyl-2-aminotetralin derivatives
10/28/1998	CN1197068A Compound and synthetic process of 3-methyl-2-phenylethylene keto-quinooxaline-1.4-dioxide
10/27/1998	US5827847 Treatment of cognitive disorders with piperazine derivatives
10/22/1998	WO1998046591A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998	CA2285335A1 Selective factor xa inhibitors

1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 187